Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.
  • Page:
  • 1
  • 2

RENOVO, TRADING 30% BELOW CASH (RNVO)     

andyeds - 04 Jul 2008 16:31

Anyone else in Renovo?

49p of cash, trading at 35p.

If Juvista is approved later this year then license fee of $825m in the bank
(approx 7 x current share price)

Rest of the pipeline thrown in for nothing...

gibby - 11 Feb 2011 13:11 - 13 of 29

dont forget:
Adaprev Reduction of adhesions following digital tendon injury Class III medical device in the EU.
Prevascar Reduction of skin scarring Phase 2

Juvidex Improve skin appearance and promote healing of damaged skin Cosmetic ingredient out-license

Adaprev Reduction of adhesions following digital tendon injury Class III medical device in the EU. Safety and preliminary performance (first of 2 trials for approval)

Prevascar Reduction of skin scarring Phase 2 - H1 2011 Proof of efficacy trial in
Juvidex Improve skin appearance and promote healing of damaged skin Cosmetic ingredient
&
RN1005
& cash in bank

gibby - 11 Feb 2011 13:14 - 14 of 29

yep they do have cash....

During the period the Company has continued to expend its cash balances developing its product portfolio. Renovos
combination of cash and cash equivalents with term deposits maturing within one year as at 31 December 2010 was
46.1 million, compared to the 51.8 million previously reported as at 30 September 2010. Renovos management
team believes that the Company is appropriately funded for continuing ongoing operations. As previously reported,
the net cash position, including investments, at the time of reporting the first Juvista EU Phase 3 trial in H1 2011 is
expected to be at least 30 million.

gibby - 11 Feb 2011 14:49 - 15 of 29

bouncing i believe!

driver - 11 Feb 2011 15:19 - 16 of 29

Not another ASM

gibby - 11 Feb 2011 15:33 - 17 of 29

its going up - still cheap for now!!!!

driver - 11 Feb 2011 15:36 - 18 of 29

18p is below cash. 40m

BAYLIS - 11 Feb 2011 17:15 - 19 of 29

Chart.aspx?Provider=EODIntra&Code=RNVO&S

gibby - 11 Feb 2011 17:25 - 20 of 29

driver -hello dude - yep 18p is below cash and they have other projects - may also make them a t/o target - now it has got interesting gonna find out more over the weekend - i so nearly invested here but the darn newspaper report sent it skying and imo didnt leave enough margin for me - however made a little beer money here today and will watch closely monday - real shock to see rnvo tank - when i saw it i thought it must be an error but it werent, feel for any caught - personally hoping for a rebound anywhere in the 20 to 30p range then of course results of other trials as they come in - gl

gibby - 11 Feb 2011 17:25 - 21 of 29

bayliss - that is one grim chart!!

hlyeo98 - 11 Feb 2011 17:52 - 22 of 29

Renovo shares plunge after Juvista trial failure


Shares in biopharma company Renovo Group plc dropped sharply after it announced the failure of its key Juvista scar-healing product in Phase III trials.

Renovo said the first EU Phase III trial for Juvista in scar revision surgery did not meet its primary or secondary endpoints.

The company would conduct further exploratory analysis and determine the future of the Juvista development programme.

CEO Professor Mark Ferguson said, 'We are extremely surprised and disappointed by the failure of Juvista to meet the Phase III trial primary and secondary endpoints.

'The board of Renovo will now consider all options open to it to maximise shareholder value.'

Shares were down to 17p at close.

gibby - 12 Feb 2011 16:18 - 23 of 29

hlyeo - yep - word is current cash is about 23-25p : i may well buy back in here monday from what i have heard:
1/ rnvo will continue and see if it is feasible to continue with juvista at all - major set back - however i would expect not due to the costs of continuing and the costs of the other trials due h1 2011
2/ Shire the jv have invested around 80M to date with rnvo and in fact there are whispers that Shire may t/o rnvo - i would like that if i can get in cheap enough again!!!
3/ rnvo will be wound up and cash back to share holders - which seems pretty good option also

all this should be decided pretty quickly - no more than 3 months imo

gla

hlyeo98 - 13 Feb 2011 10:39 - 24 of 29

Chart.aspx?Provider=EODIntra&Code=RNVO&S

driver - 13 Feb 2011 11:32 - 25 of 29

To buy back in here you need to have your finger on the sell button 24/7

gibby - 13 Feb 2011 20:55 - 26 of 29

indeed - salient point driver

he who dares and all that.....

driver - 14 Feb 2011 16:34 - 27 of 29

gibby
It didnt bounce but VAL had a good day 210% and so did RRR

gibby - 14 Feb 2011 17:39 - 28 of 29

driver - i must admit rnvo surprised me today - i saw l2 this morning and left it thankfully - went elsewhere and thankfully val did the business beyond my hopes - not unlike sar last week - so very good day hope you got some of that too - rrr yes great news great share - wont be selling up there any time soon - quite the opposite in fact - bmr was up earlyish today sold about half and bought back, was expecting more of ahh but hey ho - i hope you had a good day

will watch rnvo again tomorrow - but really it needs something pretty strategic like a t/o or they may need to wind up and return cash to share holder - we'll see
cheers

gibby - 14 Feb 2011 18:17 - 29 of 29

well rnvo been valued at 30p......

http://www.proactiveinvestors.co.uk/columns/broker-spotlight/4553/broker-roundup-gulf-keystone-petroleum-rockhopper-exploration-planet-payment-renovo-4553.html
  • Page:
  • 1
  • 2
Register now or login to post to this thread.